CYP2C19 polymorphism influences Helicobacter pylori eradication - Kuo, Chao-Hung; Lu, Chien-Yu; Shih, Hsiang-Yao; Liu, Chung-Jung; Wu, Meng-Chieh; Hu, Huang-Ming; Hsu, Wen-Hung; Yu, Fang-Jung; Wu, Deng-Chyang; Kuo, Fu-Chen (World journal of gastroenterology : WJG, 2014)
Keywords: Anti-Bacterial Agents - therapeutic use; CYP2C19; Cytochrome P-450 CYP2C19 - genetics; Cytochrome P-450 CYP2C19 - metabolism; Drug Therapy, Combination; Eradicati; Genotype; Helicobacter; Helicobacter Infections - diagnosis; Helicobacter Infections - drug therapy; Helicobacter Infections - epidemiology; Helicobacter Infections - microbiology; Helicobacter pylori - drug effects; Humans; Pharmacogenetics; Phenotype; Polymorphism; Polymorphism, Genetic; Proton Pump Inhibitors - pharmacokinetics; Proton Pump Inhibitors - therapeutic use; pylori; Topic Highlight; Treatment Outcome; Omeprazole; Helicobacter pylori; Pantoprazole; Esomeprazole; Rabeprazole; CYP2C19; Eradication; Lansoprazole; Polymorphism